Medical devices, healthcare technology and the business of care
510(k) clearance · K263033

Dental Computed Tomography X-ray System (Rubik XSmart, Rubik X1, Rubik X3) (Matrix 7000, Matrix 7800)

Fussen Technology Co., Ltd. · Decision date Sep 30, 2026

MEDTECHLEDGER EXPLANATIONK263033

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 30, 2026 for K263033, a premarket notification submitted by Fussen Technology Co., Ltd. of Shenzhen, China, received August 31, 2026. The device is a Dental Computed Tomography X-ray System under 21 CFR 892.1750, Class II, product code OAS, in the Radiology panel. The listed trade names are Rubik XSmart, Rubik X1 and Rubik X3, with models Matrix 7000 and Matrix 7800.

The submission describes a system producing cone-beam computed tomography, panoramic tomography and optional cephalometric images for diagnostic use in oral and maxillofacial regions, operated by trained professionals under physician guidance. The summary names K251842 as the predicate, also from Fussen, and reports the same indications, similar structure and comparable field-of-view, scan-time and software characteristics. The summary states no clinical study was included. SESE means clearance to market, not PMA approval; the record does not disclose performance test results or the basis for the Matrix 7000 configuration differences.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263033
Regulatory pathway
510(k) premarket notification
Product code
OAS
Decision code
SESE
Decision date
Sep 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: X-Ray, Tomography, Computed, Dental.

Product code
OAS
FDA device class
2

FDA decision timeline

  1. K263033 received

    Application receipt date recorded by FDA.

  2. K263033 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fussen Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records